PATENT CLAIM ANALYSIS

Application Number: 16019636
Application Type: Utility
Filing Date: 2018-06
Publication Date: 2018-12
Patent Classification: ["435", "235100"]

Abstract:
The invention in some aspects relates to recombinant adeno-associated viruses having distinct tissue targeting capabilities. In some aspects, the invention relates to gene transfer methods using the recombinant adeno-associate viruses. In some aspects, the invention relates to isolated AAV capsid proteins and isolated nucleic acids encoding the same.

Claim (Index 49):
An isolated AAV capsid protein comprising a sequence selected from the group consisting of: SEQ ID NOs: 151, 153, 154, and 157.

Metadata:
- Claim Count in Document: 17.0
- Percentile: 94.0
- Lexical Diversity: 1.60606
- Patent Class: 435.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['13322164', '15007559', '14246560', '15520977', '15120294']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7316483354449401
- 35 USC 102 Novelty (BERT): 0.6921042483740205
- Combined Prediction Score: 0.7276939267378482
- Mean Citation Score: 617.305788
- Max Citation Score: 731.7288
- Similarity Product: 590.1221496368407

Labels:
- Claim Label 101: 0
- Claim Label 102: 0
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 0

Dataset: test